INTELLIGENT BIO SOLUTIONS INC. current report, 28 September 2022

Business Context and Reporting Period

This Form 8-K was filed by GBS Inc. (trading symbol: GBS) on September 28, 2022. The registrant is incorporated in Delaware and is classified as an emerging growth company. The report details a specific corporate governance event regarding executive compensation rather than periodic financial results.

Key Financial Metrics

The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to the compensation package for Dr. Steven Boyages:

  • Annual Salary: $82,668
  • Directors' Fees (Chairman): $36,363
  • Annual Bonus Eligibility: Up to 20% of gross base salary
  • Superannuation Contribution: 10.5% of salary, subject to a cap of $18,944 per annum

Material Changes

On September 28, 2022, GBS Inc., through its subsidiary GBS (APAC) Pty Ltd, entered into an employment agreement with Dr. Steven Boyages. This agreement formalizes his role as Interim Chief Executive Officer and Chairman, complementing his existing directorship letter dated December 23, 2020. The agreement was approved by the Company's Compensation Committee to compensate him for additional operational oversight responsibilities.

Guidance, Outlook, and Risks

The filing contains no forward-looking guidance, market outlook, or discussion of general business risks. Specific contractual terms include:

  • Termination: The agreement is terminable on six months' notice by either party. The Company may terminate without notice for serious misconduct, negligence, breach of contract, bringing the Company into disrepute, or criminal conviction.
  • Restrictive Covenants: Includes provisions protecting confidential information and intellectual property. A non-compete clause restricts Dr. Boyages from competing with the Company during employment and for up to six months thereafter in a specified geographic region, including restrictions on soliciting employees or clients.

Investor Verification Checklist

  • Verify the full text of the Employment Agreement attached as Exhibit 10.1 for complete legal terms.
  • Confirm the impact of the new executive compensation on the company's overall burn rate and cash position.
  • Review the specific geographic region defined in the non-compete clause to assess its scope.
  • Check subsequent filings for updates on the company's operational status under the new interim leadership.